Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17825-15-9

Post Buying Request

17825-15-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • ethyl 4-oxo-7-phenylmethoxy-1H-quinoline-3-carboxylate

    Cas No: 17825-15-9

  • USD $ 1.5-1.5 / Metric Ton

  • 1 Metric Ton

  • 1000 Metric Ton/Day

  • KAISA GROUP INC
  • Contact Supplier

17825-15-9 Usage

Description

7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER is a chemical compound derived from the quinoline family, featuring a 4-hydroxyquinoline core with a benzyl group and an ethyl ester functional group attached. 7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER holds potential in pharmaceutical applications and as a synthetic intermediate in organic chemistry, with possible biological activity due to its structural resemblance to other bioactive quinoline compounds. Further research is required to explore its full potential and effects.

Uses

Used in Pharmaceutical Industry:
7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER is used as a pharmaceutical candidate for its potential therapeutic applications, leveraging its structural attributes and possible biological activity. Its use in this industry is driven by the need for novel compounds with unique mechanisms of action.
Used as a Synthetic Intermediate in Organic Chemistry:
In the field of organic chemistry, 7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER serves as a synthetic intermediate, facilitating the creation of more complex molecules and contributing to the advancement of chemical synthesis techniques. Its role here is to provide a building block for the development of new compounds with various applications.
Used in Biological Research:
7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER is utilized in biological research to investigate its potential biological activity, given its structural similarity to other bioactive quinoline compounds. This application is crucial for understanding its interactions with biological systems and identifying possible therapeutic targets or mechanisms of action.

Check Digit Verification of cas no

The CAS Registry Mumber 17825-15-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,8,2 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 17825-15:
(7*1)+(6*7)+(5*8)+(4*2)+(3*5)+(2*1)+(1*5)=119
119 % 10 = 9
So 17825-15-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H17NO4/c1-2-23-19(22)16-11-20-17-10-14(8-9-15(17)18(16)21)24-12-13-6-4-3-5-7-13/h3-11H,2,12H2,1H3,(H,20,21)

17825-15-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4-oxo-7-phenylmethoxy-1H-quinoline-3-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl 7-benzyloxy-4-oxo-1,4-dihydro-quinoline-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17825-15-9 SDS

17825-15-9Relevant articles and documents

Computer-Aided Molecular Modeling, Synthesis, and Biological Evaluation of 8-(Benzyloxy)-2-phenylpyrazoloquinoline as a Novel Benzodiazepine Receptor Agonist Ligand

Wang, C.-G.,Langer, T.,Kamath, P. G.,Gu, Z.-Q.,Skolnick, P.,Fryer, R. Ian

, p. 950 - 957 (2007/10/02)

Using computer-aided conformational analysis, based on molecular dynamics simulation, cluster analysis, and Monte Carlo techniques, we have designed and synthesized compounds in which a benzyloxy substituent has been incorporated into a series of pyrazoloquinoline benzodiazepine receptor (BZR) ligands.Earlier studies had shown that the benzyloxy group could act as part of the agonist pharmacophoric determinant in the β-carboline ring system.Furthermore, the agonist β-carboline had been correlated with a binding site orientation and volume fit for an agonist 6-phenylimidazobenzodiazepine carboxylate.The present study was undertaken to determine whether the benzyloxy substituent could be used as an agonist pharmacophoric descriptor for the phenylpyrazoloquinolin-3-one BZR ligands.The results of a determination of GABA shift ratios for the synthetic ligands indicate that 8-(benzyloxy)-2-phenylpyrazoloquinolin-3-one can be predicted to be an agonist at the BZR.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17825-15-9